Advancements in cancer treatment over the past few decades have led to a remarkable increase in survival rates, transforming cancer into a chronic condition for many patients rather than a terminal diagnosis. Current projections estimate that by 2032, the global population of cancer survivors will reach approximately 22.5 million. This burgeoning survivor population underscores a critical need for a robust and sustainable model of post-treatment care that addresses not only the medical but also the psychosocial complexities faced by individuals after they have completed their primary cancer therapies.
Cancer survivorship care encompasses a multifaceted approach that extends beyond the management of residual physical side effects from treatments such as chemotherapy, radiation, or surgery. It involves continuous surveillance for recurrence, screening for secondary malignancies, management of long-term treatment toxicities, and integration of mental health support. Given the varied nature of these needs, the delivery of surveillance and supportive care is inherently complex and demands coordinated efforts among multiple healthcare providers.
In recent exploratory research conducted by the University of Missouri School of Medicine, investigators delved into the experiences of female cancer survivors transitioning from acute oncology care to longer-term survivorship management overseen largely by primary care clinicians (PCCs). This stratified care shift aims to leverage the longitudinal and holistic relationship that primary care providers have with patients, but the study illuminated significant systemic and practical challenges impeding continuity of care. Among the 57 women surveyed and interviewed, only about one-third reported consistent contact with the same primary care clinician post-treatment, highlighting fragmentation risks.
.adsslot_M5FZIAQ1sx{ width:728px !important; height:90px !important; }
@media (max-width:1199px) { .adsslot_M5FZIAQ1sx{ width:468px !important; height:60px !important; } }
@media (max-width:767px) { .adsslot_M5FZIAQ1sx{ width:320px !important; height:50px !important; } }
ADVERTISEMENT
The fragmented nature of survivorship care stems in part from unclear delineations of roles and responsibilities between oncologists and primary care practitioners. When transitioning patients after active treatment, ambiguity regarding who is accountable for surveillance protocols, symptom management, and psychological support can cause gaps in care continuity. Miscommunications between specialties and lapses in patient-provider relationships may exacerbate these discontinuities, potentially compromising early detection of recurrence or management of late effects.
Moreover, the research resonates with findings from previous studies that many primary care providers experience a lack of confidence and preparedness to deliver comprehensive survivorship care. Despite their willingness to engage in additional training, PCCs often cite insufficient educational resources and ambiguous clinical guidelines as barriers. This gap presents an opportunity for integrating targeted educational programs within primary care training frameworks to enhance preparedness for survivorship challenges.
Notably, the research team identifies several promising educational interventions designed to equip primary care clinicians with the necessary knowledge and skills. These include modular online courses, interactive workshops, webinars, and tele-mentoring programs like the Extension for Community Healthcare Outcomes (ECHO) model. The ECHO program, in particular, facilitates remote collaboration and case-based learning between oncology specialists and primary care teams, promoting shared expertise and improved patient outcomes.
The study also underscores the preference among many cancer survivors for shared-care models, where primary care and oncology specialists collaboratively engage in ongoing management. Shared-care approaches capitalize on the strengths of both disciplines: oncologists bring in-depth knowledge of cancer-specific risks and therapies, while PCCs offer longitudinal oversight of overall health, comorbidities, and preventive care. Such models can foster patient-centered continuity and potentially mitigate fragmentation.
Looking forward, the researchers aim to expand investigations into the evolving needs and preferences of cancer survivors during the survivorship phase. Understanding nuanced patient priorities—ranging from symptom management and psychosocial support to communication preferences—will be critical in designing survivorship care pathways that are not only clinically effective but also aligned with patients’ lived experiences and expectations.
This body of work contributes valuable insights into the structural and educational reforms necessary to optimize cancer survivorship care. As the survivor population grows, health systems must innovate integrated care models that adequately support primary care clinicians, promote seamless specialty-primary care coordination, and address the holistic needs of survivors.
The broader implications of these findings highlight a pressing need for policy initiatives and resource allocation to enhance survivorship training and care infrastructure. Investing in scalable educational platforms and fostering multidisciplinary collaboration will be key to meeting the anticipated demand for comprehensive survivorship services.
In sum, while advances in oncology have significantly improved survival, the continuum of care beyond treatment remains riddled with challenges. Empowering primary care providers through targeted education and structured collaborative models offers a promising avenue to bridge existing gaps. This approach is poised to redefine survivorship care and improve outcomes for millions who navigate life after cancer treatment.
The observational study titled “Continuity of Cancer Care: Female Participants’ Report of Healthcare Experiences After Conclusion of Primary Treatment” was published in the July 2025 issue of Current Oncology. Authored by experts including Jane McElroy, PhD, of the University of Missouri’s Department of Family and Community Medicine, and Mirna Becevic, PhD, from the Department of Dermatology, the study highlights essential directions for future cancer survivorship research and clinical practice.
Subject of Research: People
Article Title: Continuity of Cancer Care: Female Participants’ Report of Healthcare Experiences After Conclusion of Primary Treatment
News Publication Date: 11-Jul-2025
Web References:
DOI: 10.3390/curroncol32070399
Keywords:
Family medicine, Oncology, Cancer patients, Cancer screening, Preventive medicine, Cancer treatments
Tags: cancer survivorship carechronic illness management for cancer patientshealthcare provider collaboration in oncologyimproving cancer patient outcomeslong-term effects of cancer treatmentmental health in cancer survivorshipmultidisciplinary approach to cancer careprimary care coordination in oncologypsychosocial support for cancer survivorssecondary malignancies in cancer survivorssurveillance for cancer recurrencetransitioning from oncology to primary care